Back to results
US 2023/0416706 A1Published application
Dnase Variants
AssigneeNovozymes A/S
InventorsLars Beier, Klaus Gori, Lars Henrik Oestergaard, Lars Giger, Annette Helle Johansen, Gernot J. Abel
Life of this patent
Estimating the term…
Abstract
The present invention relates to polypeptide variants and methods for obtaining variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Claims17
1-13. (canceled)
A polypeptide variant having DNase activity, wherein the variant comprises at least five substitutions selected from the group consisting of:
- T1I or T1V,
- G4K,
- S7G,
- K8R,
- S9I,
- S13Y,
- T22P,
- S25P,
- S27L,
- S27R,
- D32I, D32L, D32R, or D32V,
- L33R or L33K,
- S39P or S39C,
- G41P,
- S42G, S42H, or S42C,
- Q48D,
- D561 or D56L,
- S57W,
- S59V or S59C,
- N61E,
- T65L, T65V, T65M, or T65W,
- S66M, S66W, S66Y, or S66V,
- V76L,
- T77Y,
- F78L,
- P91L,
- S101N,
- S106L, S106R, or S106H,
- Q109R,
- A112E,
- S116D,
- T127V,
- S130A or S130Y,
- T138D,
- Q140V or Q140G,
- S144P,
- A147H,
- C148A,
- W154Y,
- T157V,
- Y159A or Y159R,
- K160V,
- G162S, G162D, or G162C,
- Q166D,
- S167L,
- Q174N,
- G175D or G175N,
- L177Y,
- N178D or N178E,
- S179L,
- C180A, and
- S181E or S181L,
- wherein
- each position corresponds to the position of the polypeptide of SEQ ID NO:
- 1, and
- the variant has at least 80% sequence identity to the amino acid sequence of SEQ ID NO:
- 1.
54 more elements
17-18. (canceled)
(canceled)
Dependencies are inferred from the claim text.